Richard Fairman

Chief Executive Officer, Cvs

Search every verified Richard Fairman interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In March 2022, Richard Fairman reported the interim results for CVS Group for the period ending 31 December 2021. He stated that total sales increased by 11.4% to £273.7 million, with like-for-like sales up 11.3% and adjusted EBITDA rising 15.5% to £52 million. Fairman said the company had continued its positive momentum into the first two months of the second half. He noted that the group remained focused on its four strategic pillars of clinical care, being a great place to work, having the best facilities and equipment, and taking responsibilities seriously. Fairman also said CVS aimed to grow through improving existing operations, recruitment and retention, increased investment in facilities, selective acquisitions, and greenfield sites. Fairman described the market dynamics as positive, citing an increase in the companion animal population due to the pandemic, though he said the full benefit was not expected for five to ten years. He added that the humanization of pets trend continued and that consumers wanted the best possible care for their animals. He also said the group was "naturally disappointed" with the Competition and Markets Authority's decision regarding an acquisition, but that the company had taken a pragmatic approach and the decision was helpful for assessing future acquisition opportunities.